.png)

Certified CE and FDA K 190894 Class II
.png)
.png)
C.O.E. SM26889
Sealed and ready for use
Limits movement and enables reproducibility of the patient position
Conform to shape easily during stiffening phase
Disposable, easy to sanitize markable and radio transparent
Can be formed and indexed to positioning devices and other rigid supports
Pediatric options available

2025 TOTIM® - ESSEBI MEDICAL, All Rights Reserved©
TOTIM have been proven to reduce preparation time, especially for difficult set-ups
Reducing rates of misalignments reduces the number of repeated port films, saving therapists and physicians valuable time
The device is used in a healthcare facility hospital. The device is intended to be used on adult and pediatric patients.
TOTIM® Cushion form by activation of internal component to then shape and mold around the patient.
Does not require vacuum or water activation process to form rigid cushion
NO AIR OR MOISTURE ACTIVATION - NO PPE USE



























TOTIM® is a polyurethane foam positioning system using fully sealed bag/cushion
The device can be attached to the treatment or simulation couch, extension, or overlay along with other optional positioning and immobilization devices and accessories.
Materials: Cushion in Microfiber Polyester / PU (fully sealed) and internal pouch (fully sealed) with inside the two reagents ready to be mixed.
Non-clinical testing was completed to confirm that TOTIM is safe and effective device.
A scientific rationale was used to address RF heating, magnetically induced torque, and magnetically induced displacement force.
The TOTIM® device was tested with ASTM F2119-07 (Reapproved 2013) Standard Test Method for Evaluation of MR Image Artifacts from Passive Implants (Materials). The cushion is MR Safe, is manufactured of non-magnetic materials
Proton Test Water Equivalent Thickness (WET) Values: to verify that the product to not negatively impact a proton team when measured orthogonally through the permissible radiation area.
Conclusion: the product tested do not perturb or impact the proton beam in a way that cannot be accounted for in the proton treatment planning process.
- The devices are intended for limited contact duration (<24 hours) for surface devices (skin).
Biocompatibility: ISO 10993-5:2009, 10993-12: 2012 and ISO 10993-10: 2010.
TOTIM CONFORMITY
PUBLICATIONS TOTIM